M&A Deal Summary |
|
---|---|
Date | 2016-02-22 |
Target | SomPharmaceuticals S.A |
Sector | Life Science |
Buyer(s) | Amryt Pharma |
Deal Type | Add-on Acquisition |
Deal Value | 30M GBP |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Sector | Life Science |
Employees | 182 |
Revenue | 182M GBP (2020) |
Amryt Pharma is a pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma is based in Dublin, Ireland.
DEAL STATS | # |
---|---|
Overall | 2 of 4 |
Sector (Life Science) | 2 of 4 |
Type (Add-on Acquisition) | 2 of 4 |
Country (Switzerland) | 1 of 1 |
Year (2016) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-02-22 |
Birken AG
Niefern-Oschelbronn, Germany Birken AG is a pharmaceutical development and manufacturing company. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-05-21 |
Aegerion Pharmaceuticals
Cambridge, Massachusetts, United States Aegerion Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical products to treat cardiovascular and metabolic diseases. Aegerion Pharmaceuticals, Inc. was formed in 2005 and is headquartered in Cambridge, Massachusetts. |
Buy | - |